Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing

Mycoses. 2018 Jan;61(1):44-47. doi: 10.1111/myc.12709. Epub 2017 Oct 16.

Abstract

Candida auris is an emerging multidrug-resistant (MDR) fungus associated with invasive infections and high mortality. This report describes 9 patients from whom C. auris was isolated at a hospital in Panama City, Panama, the first such cases in Central America, and highlights the challenges of accurate identification and methods for susceptibility testing.

Keywords: Candida auris; acurate; diagnose; susceptibility.

MeSH terms

  • Adult
  • Aged
  • Antifungal Agents / pharmacology*
  • Antifungal Agents / therapeutic use
  • Candida / drug effects*
  • Candida / isolation & purification*
  • Candida / pathogenicity
  • Candidiasis / diagnosis*
  • Candidiasis / epidemiology
  • Candidiasis / mortality
  • Drug Resistance, Multiple, Fungal
  • Female
  • Humans
  • Intensive Care Units
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Panama / epidemiology
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Young Adult

Substances

  • Antifungal Agents